comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-06 04:13:03 - browse：1823

Erik Tokat -- biotech JPM coverage from STAT — Eric Tokat is co-president of investment banking at Centerview Partners. Courtesy Centerview Partners

SAN FRANCISCO — Eric Tokat, biotech’s most prolific dealmaker, believes 2024 will be another strong year for acquisitions, driven by Big Pharma’s need to restock pipelines with medicines that can generate sales in the coming years.

That’s not idle speculation. It’s perhaps as close to a guarantee one can get in biotech. Last year, Tokat’s advisory firm, Centerview Partners, was involved in 19 of the 23 biotech transactions valued at $1 billion or more. Two more acquisitions of Centerview clients — Harpoon Therapeutics and Ambrx Biopharma — were announced Monday morning.

“I’m not sure if we’re going to have 23 deals or 25 deals, but I think it’s going to be a good year,” said Tokat, speaking to STAT over coffee on the sidelines of the J.P. Morgan Healthcare Conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Cigna wins case to block Amy Bricker's move to CVS

WSS

Statins may not be needed by millions of people, study suggests

7 more heat

EF3 tornado rips through North Carolina amid extreme weather nationwide

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

ALS patient reclaims some autonomy thanks to wearable 'robot'

Mass General totes up its waste in a move to tackle climate change

Wikipedia

comprehensive

knowledge

Wildfire smoke exposes gaps in outdoor worker protections

California wildfire smoke linked to 52,000 early deaths, study says

Activists slam private health insurers over coverage restrictions

Stanford president's case begs question: Who takes blame?

Medicare details structure of new drug price negotiation program

Why Congress must ban federal programs from using QALYs

Sports medicine is finally prioritizing gender equality

Health care court cases: Humana, Sutter, Novant

Psychedelics group wrestles with new pharma identity

Awakening the world to the whoosh: A patient's crusade

explore

STAT Virtual Event: ASCO Recap, Live!

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Hospitals struggle to profit from CAR

Driven by the pandemic, applicants flood public health schools

Teladoc has a new CEO, but challenges remain the same

hotspot

hotspot

explore

hotspot